International Nuclear Medicine Consensus on the Clinical Use of Amyloid Positron Emission Tomography in Alzheimer's Disease
Tian, Mei (The Second Affiliated Hospital of Zhejiang University School of Medicine)
Zuo, Chuantao (Fudan University)
Civelek, A. Cahid (Johns Hopkins Medicine)
Carrió, Ignasi (Institut d'Investigació Biomèdica Sant Pau)
Watanabe, Yasuyoshi (RIKEN Center for Biosystems Dynamics Research)
Kang, Keon Wook (Seoul National University College of Medicine)
Murakami, Koji (Juntendo University Hospital)
Garibotto, Valentina (University of Geneva)
Prior, John O. (Lausanne University Hospital)
Barthel, Henryk (Leipzig University Medical Center)
Guan, Yihui (Fudan University)
Lu, Jiaying (Fudan University)
Zhou, Rui (The Second Affiliated Hospital of Zhejiang University School of Medicine)
Jin, Chentao (The Second Affiliated Hospital of Zhejiang University School of Medicine)
Wu, Shuang (The Second Affiliated Hospital of Zhejiang University School of Medicine)
Zhang, Xiaohui (The Second Affiliated Hospital of Zhejiang University School of Medicine)
Zhong, Yan (The Second Affiliated Hospital of Zhejiang University School of Medicine)
Zhang, Hong (Zhejiang University)
Universitat Autònoma de Barcelona

Data:	2023
Resum:	Alzheimer's disease (AD) is the main cause of dementia, with its diagnosis and management remaining challenging. Amyloid positron emission tomography (PET) has become increasingly important in medical practice for patients with AD. To integrate and update previous guidelines in the field, a task group of experts of several disciplines from multiple countries was assembled, and they revised and approved the content related to the application of amyloid PET in the medical settings of cognitively impaired individuals, focusing on clinical scenarios, patient preparation, administered activities, as well as image acquisition, processing, interpretation and reporting. In addition, expert opinions, practices, and protocols of prominent research institutions performing research on amyloid PET of dementia are integrated. With the increasing availability of amyloid PET imaging, a complete and standard pipeline for the entire examination process is essential for clinical practice. This international consensus and practice guideline will help to promote proper clinical use of amyloid PET imaging in patients with AD.
Drets:	Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, la comunicació pública de l'obra i la creació d'obres derivades, fins i tot amb finalitats comercials, sempre i quan es reconegui l'autoria de l'obra original.
Llengua:	Anglès
Document:	Article ; recerca ; Versió publicada
Matèria:	Alzheimer's disease ; Amyloid ; Brain imaging ; Expert consensus ; Positron emission tomography (PET)
Publicat a:	Phenomics, Vol. 3 Núm. 4 (august 2023) , p. 375-389, ISSN 2730-5848

DOI: 10.1007/s43657-022-00068-9
PMID: 37589025

15 p, 993.6 KB

El registre apareix a les col·leccions:
Documents de recerca > Documents dels grups de recerca de la UAB > Centres i grups de recerca (producció científica) > Ciències de la salut i biociències > Institut de Recerca Sant Pau
Articles > Articles de recerca
Articles > Articles publicats